119 related articles for article (PubMed ID: 8713784)
1. Fat emulsion infusion potentiates coagulation activation during human endotoxemia.
van der Poll T; Coyle SM; Levi M; Boermeester MA; Braxton CC; Jansen PM; Hack CE; Lowry SF
Thromb Haemost; 1996 Jan; 75(1):83-6. PubMed ID: 8713784
[TBL] [Abstract][Full Text] [Related]
2. Dobutamine does not influence inflammatory pathways during human endotoxemia.
Lemaire LC; de Kruif MD; Giebelen IA; Levi M; van der Poll T; Heesen M
Crit Care Med; 2006 May; 34(5):1365-71. PubMed ID: 16540959
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees.
Levi M; ten Cate H; Bauer KA; van der Poll T; Edgington TS; Büller HR; van Deventer SJ; Hack CE; ten Cate JW; Rosenberg RD
J Clin Invest; 1994 Jan; 93(1):114-20. PubMed ID: 8282778
[TBL] [Abstract][Full Text] [Related]
4. The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia.
Spiel AO; Firbas C; Mayr FB; Leitner JM; Schmidt B; Knöbl P; Varadi K; Jilma B
Thromb Haemost; 2005 Dec; 94(6):1148-55. PubMed ID: 16411386
[TBL] [Abstract][Full Text] [Related]
5. Effects of IC14, an anti-CD14 antibody, on coagulation and fibrinolysis during low-grade endotoxemia in humans.
Verbon A; Meijers JC; Spek CA; Hack CE; Pribble JP; Turner T; Dekkers PE; Axtelle T; Levi M; van Deventer SJ; Reitsma PH; van der Poll T
J Infect Dis; 2003 Jan; 187(1):55-61. PubMed ID: 12508146
[TBL] [Abstract][Full Text] [Related]
6. Recombinant tumor necrosis factor receptor p75 fusion protein (TNFR:Fc) alters endotoxin-induced activation of the kinin, fibrinolytic, and coagulation systems in normal humans.
DeLa Cadena RA; Majluf-Cruz A; Stadnicki A; Tropea M; Reda D; Agosti JM; Colman RW; Suffredini AF
Thromb Haemost; 1998 Jul; 80(1):114-8. PubMed ID: 9684796
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia.
Pajkrt D; Lerch PG; van der Poll T; Levi M; Illi M; Doran JE; Arnet B; van den Ende A; ten Cate JW; van Deventer SJ
Thromb Haemost; 1997 Feb; 77(2):303-7. PubMed ID: 9157586
[TBL] [Abstract][Full Text] [Related]
8. Pharmacodynamics of active site-inhibited factor VIIa in endotoxin-induced coagulation in humans.
Jilma B; Marsik C; Mayr F; Graninger MT; Taylor FB; Ribel MC; Erhardtsen E; Handler S; Eichler HG
Clin Pharmacol Ther; 2002 Oct; 72(4):403-10. PubMed ID: 12386642
[TBL] [Abstract][Full Text] [Related]
9. Effect of short-term intralipid infusion on the immune response during low-dose endotoxemia in humans.
Krogh-Madsen R; Plomgaard P; Akerstrom T; Møller K; Schmitz O; Pedersen BK
Am J Physiol Endocrinol Metab; 2008 Feb; 294(2):E371-9. PubMed ID: 18056792
[TBL] [Abstract][Full Text] [Related]
10. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa.
Biemond BJ; Levi M; ten Cate H; Soule HR; Morris LD; Foster DL; Bogowitz CA; van der Poll T; Büller HR; ten Cate JW
Thromb Haemost; 1995 Feb; 73(2):223-30. PubMed ID: 7792734
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolytic response to interferon-alpha in healthy human subjects.
Corssmit EP; Levi M; Hack CE; ten Cate JW; Sauerwein HP; Romijn JA
Thromb Haemost; 1996 Jan; 75(1):113-7. PubMed ID: 8713789
[TBL] [Abstract][Full Text] [Related]
12. Changes in HLA-DR expression, cytokine production and coagulation following endotoxin infusion in healthy human volunteers.
Mant TG; Borozdenkova S; Bradford DB; Allen E; Amin DM; Toothaker RD; Collins RW; Hargreaves RE; Jurcevic S
Int Immunopharmacol; 2008 May; 8(5):701-7. PubMed ID: 18387512
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia.
Renckens R; Weijer S; de Vos AF; Pater JM; Meijers JC; Hack CE; Levi M; van der Poll T
Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):483-8. PubMed ID: 14739127
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II infusion in man is proinflammatory but has no short-term effects on thrombin generation in vivo.
Ekholm M; Kahan T; Jörneskog G; Bröijersen A; Wallén NH
Thromb Res; 2009 May; 124(1):110-5. PubMed ID: 19195683
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human antithrombin inhibits thrombin formation and interleukin 6 release in human endotoxemia.
Leitner JM; Firbas C; Mayr FB; Reiter RA; Steinlechner B; Jilma B
Clin Pharmacol Ther; 2006 Jan; 79(1):23-34. PubMed ID: 16413239
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia.
de Jonge E; Dekkers PE; Creasey AA; Hack CE; Paulson SK; Karim A; Kesecioglu J; Levi M; van Deventer SJ; van Der Poll T
Blood; 2000 Feb; 95(4):1124-9. PubMed ID: 10666180
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees.
Levi M; van Der POLL T; ten CATE H; Kuipers B; Biemond BJ; Jansen HM; ten CATE JW
Am J Respir Crit Care Med; 1998 Jul; 158(1):92-8. PubMed ID: 9655712
[TBL] [Abstract][Full Text] [Related]
18. Effects of activated protein C on coagulation and fibrinolysis in rabbits with endotoxin induced acute lung injury.
He HY; Wang C; Pang BS
Chin Med J (Engl); 2008 Dec; 121(24):2561-5. PubMed ID: 19187596
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of endotoxin-induced activation of the coagulation and fibrinolytic pathways using a recombinant endotoxin-binding protein (rBPI23).
von der Möhlen MA; van Deventer SJ; Levi M; van den Ende B; Wedel NI; Nelson BJ; Friedmann N; ten Cate JW
Blood; 1995 Jun; 85(12):3437-43. PubMed ID: 7780131
[TBL] [Abstract][Full Text] [Related]
20. Effects of IL-10 on systemic inflammatory responses during sublethal primate endotoxemia.
van der Poll T; Jansen PM; Montegut WJ; Braxton CC; Calvano SE; Stackpole SA; Smith SR; Swanson SW; Hack CE; Lowry SF; Moldawer LL
J Immunol; 1997 Feb; 158(4):1971-5. PubMed ID: 9029140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
